Healthcare -
Biotechnology - NASDAQ - US
$ 6.42
1.42 %
$ 570 M
Market Cap
-2.73
P/E
VERV - TOTAL CURRENT LIABILITIES
Total Current Liabilities VERV - Verve Therapeutics, Inc.
37 M
LAST VALUE
29.62%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR